Gloucestershire Health and Care- NHS Trust logo
with you, for you
Responses > GLP-1 receptor agonists prior to OGD

Freedom of Information request GLP-1 receptor agonists prior to OGD

Response published: 5 May 2026
GHNHSFT - Redirect

FOI Request

Dear Sir/Madam, I am writing to request information under the Freedom of Information Act 2000 regarding your Trust’s guidance and practice relating to the management of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) prior to upper gastrointestinal endoscopy (oesophago-gastro-duodenoscopy, OGD). This request forms part of a national study assessing variation in NHS Trust practice. ⸻ Information Requested 1. Guidance Availability a) Does your Trust have any guidance, protocol, or policy relating to the management of GLP-1 receptor agonists prior to OGD? b) If yes, please provide:       •     A copy of the guidance, or       •     A link to where it is publicly available 2. Medication Management a) What is your Trust’s recommendation regarding oral GLP-1 receptor agonists prior to OGD? (e.g. continue, omit morning dose, withhold for a defined period) b) What is your Trust’s recommendation regarding injectable GLP-1 receptor agonists prior to OGD? 3. Indication-Specific Guidance a) Does your Trust differentiate guidance based on indication (e.g. diabetes vs obesity)? b) If yes, please outline how recommendations differ. 4. Fasting Protocol a) Does your Trust modify fasting instructions for patients taking GLP-1 receptor agonists prior to OGD? b) If yes, please provide details of the modified fasting protocol. 5. Operational Impact a) Has your Trust identified any impact of GLP-1 receptor agonist use on OGD procedures (e.g. cancellations, retained gastric contents, aspiration risk)? b) If recorded, please provide any available data or summary information. 6. Governance a) Has the management of GLP-1 receptor agonists in endoscopy been discussed, reviewed, or audited within your Trust? Format of Response Please provide the information in electronic format where possible. If any part of this request exceeds cost limits, I would be grateful if you could:       •     Advise how the request may be refined or   •     Provide the information that falls within the allowable limit Clarification This request relates only to adult elective OGD procedures and excludes colonoscopy or other endoscopic procedures unless included within a shared protocol. Additional Notes Where exact data is not held, a summary of local practice or clinical guidance is acceptable. Thank you for your time and assistance. I look forward to your response within the statutory 20 working days.

FOI Response

Freedom of Information Request – Ref: FOI GHC-29042026-730911

Thank you for your recent Freedom of Information request. Please find our response below.

You asked:

1. Guidance Availability

a) Does your Trust have any guidance, protocol, or policy relating to the management of GLP-1 receptor agonists prior to OGD?

b) If yes, please provide:
•     A copy of the guidance, or
•     A link to where it is publicly available

2. Medication Management

a) What is your Trust’s recommendation regarding oral GLP-1 receptor agonists prior to OGD? (e.g. continue, omit morning dose, withhold for a defined period)

b) What is your Trust’s recommendation regarding injectable GLP-1 receptor agonists prior to OGD?

3. Indication-Specific Guidance

a) Does your Trust differentiate guidance based on indication (e.g. diabetes vs obesity)?

b) If yes, please outline how recommendations differ.

4. Fasting Protocol

a) Does your Trust modify fasting instructions for patients taking GLP-1 receptor agonists prior to OGD?

b) If yes, please provide details of the modified fasting protocol.

5. Operational Impact

a) Has your Trust identified any impact of GLP-1 receptor agonist use on OGD procedures (e.g. cancellations, retained gastric contents, aspiration risk)?

b) If recorded, please provide any available data or summary information.

6. Governance

a) Has the management of GLP-1 receptor agonists in endoscopy been discussed, reviewed, or audited within your Trust?

Format of Response Please provide the information in electronic format where possible. If any part of this request exceeds cost limits, I would be grateful if you could:

•     Advise how the request may be refined

or

•     Provide the information that falls within the allowable limit

Clarification

This request relates only to adult elective OGD procedures and excludes colonoscopy or other endoscopic procedures unless included within a shared protocol.

Additional Notes

Where exact data is not held, a summary of local practice or clinical guidance is acceptable.

Our response:

The Trust does not provide the service mentioned in your request. Please re-direct your request to Gloucestershire Hospitals NHS Foundation Trust at ghn-tr.foi@nhs.net.

Next steps:

Should you have any queries in relation to our response, please do not hesitate to contact us. If you are unhappy with the response you have received in relation to your request and wish to ask us to review our response, you should write to:

Louise Moss
Head of Legal Services / Associate Director of Corporate Governance
c/o Gloucestershire Health and Care NHS Foundation Trust
Edward Jenner Court
1010 Pioneer Avenue
Gloucester Business Park
Brockworth, GL3 4AW
E-mail: louise.moss@ghc.nhs.uk

If you are not content with the outcome of any review, you may apply directly to the Information Commissioner’s Office (ICO) for further advice/guidance. Generally, the ICO will not consider your case unless you have exhausted your enquiries with the Trust which should include considering the use of the Trust’s formal complaints procedure. The ICO can be contacted at: The Information Commissioner’s Office, Wycliffe House, Water Lane, Wilmslow, Cheshire SK9 5AF.